Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioma × Tetanus Toxoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Lipodystrophy, Congenital Generalized 1 Glioma 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Temozolomide 59 Bevacizumab 37 Radiotherapy 19 Magnetic Resonance Spectroscopy 18 Irinotecan 16 Carboplatin 10 Specimen Handling 9 Carmustine 9 olaparib 6 X-Rays 6 Surgical Procedures, Operative 6 Phantoms, Imaging 6 Cyclophosphamide 6 Thalidomide 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Biopsy 5 trametinib 4 pembrolizumab 4 Radiation 4 Lomustine 4 Everolimus 4 Cisplatin 4 Aminolevulinic Acid 4 sargramostim 3 poly ICLC 3 palbociclib 3 ivosidenib 3 fluorodopa F 18 3 erdafitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡